Form 4: Doximity Director Sells Shares Under 10b5-1 Plan

A Doximity, Inc. director exercised stock options and sold 2,000 Class A Common Stock shares for $66.57 each, as part of a pre-arranged trading plan.

Summary

• Kira Scherer Wampler, a Director of Doximity, Inc., executed a series of transactions on September 2, 2025, involving the company's equity.
• Wampler exercised 2,000 stock options at an exercise price of $1.54 per share, which were granted on June 10, 2020, and vested in 36 equal monthly installments after March 27, 2020.
• The exercise resulted in the acquisition of 2,000 shares of Class B Common Stock, which were subsequently converted into 2,000 shares of Class A Common Stock.
• Following the conversion, 2,000 shares of Class A Common Stock were sold at a price of $66.57 per share.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2024.
• After these transactions, Wampler directly holds 19,839 shares of Class A Common Stock and 468,700 stock options for Class B Common Stock.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider transaction (exercise and sale) under a Rule 10b5-1 plan. This type of transaction is generally neutral in sentiment as it does not typically signal new fundamental information about the company.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a systematic approach to managing equity rather than a reaction to new, adverse information.
• The exercise of stock options suggests that the director previously held a positive outlook on the company's long-term value.

Negatives

• Insider selling, even if pre-planned, can sometimes be perceived negatively by the market, although the amount here is relatively small.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The sales reported occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2024.

Industry Context

Insider transactions, particularly those executed under Rule 10b5-1 plans, are a routine aspect of executive compensation and personal financial management in publicly traded companies. They generally do not reflect new information about the company's operational performance or strategic direction, but rather pre-scheduled liquidity events for insiders.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in a director's direct Class A holdings, which is a routine event for insiders managing their equity. Given it's a pre-planned sale, it is unlikely to significantly impact shareholder sentiment or the company's valuation.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

The filing details a routine, pre-planned insider transaction (exercise and sale) under a Rule 10b5-1 plan. This type of transaction typically does not signal a change in the company's fundamental outlook or warrant a change in investment recommendation. Investors should continue to evaluate Doximity based on its operational performance, financial results, and market position.

Keywords

Doximity, DOCS, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Director, Equity, Shares, Stock Options